» Articles » PMID: 33311482

Ferroptotic Damage Promotes Pancreatic Tumorigenesis Through a TMEM173/STING-dependent DNA Sensor Pathway

Overview
Journal Nat Commun
Specialty Biology
Date 2020 Dec 14
PMID 33311482
Citations 161
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis is a more recently recognized form of cell death that relies on iron-mediated oxidative damage. Here, we evaluate the impact of high-iron diets or depletion of Gpx4, an antioxidant enzyme reported as an important ferroptosis suppressor, in the pancreas of mice with cerulean- or L-arginine-induced pancreatitis, and in an oncogenic Kras murine model of spontaneous pancreatic ductal adenocarcinoma (PDAC). We find that either high-iron diets or Gpx4 depletion promotes 8-OHG release and thus activates the TMEM173/STING-dependent DNA sensor pathway, which results in macrophage infiltration and activation during Kras-driven PDAC in mice. Consequently, the administration of liproxstatin-1 (a ferroptosis inhibitor), clophosome-mediated macrophage depletion, or pharmacological and genetic inhibition of the 8-OHG-TMEM173 pathway suppresses Kras-driven pancreatic tumorigenesis in mice. GPX4 is also a prognostic marker in patients with PDAC. These findings provide pathological and mechanistic insights into ferroptotic damage in PDAC tumorigenesis in mice.

Citing Articles

New insights into tRNA-derived small RNAs in human digestive diseases.

Liu Y, Chen F, Zhang F, Ye Y, Su Y, Liu Y Mol Biol Rep. 2025; 52(1):295.

PMID: 40063289 DOI: 10.1007/s11033-025-10393-7.


Ferroptosis enhances the therapeutic potential of oncolytic adenoviruses KD01 against cancer.

Li W, Ji T, Ye J, Xiong S, Si Y, Sun X Cancer Gene Ther. 2025; .

PMID: 40033102 DOI: 10.1038/s41417-025-00882-z.


A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development.

Schneider A, Koppe C, Crouchet E, Papargyriou A, Singer M, Buttner V Nat Commun. 2025; 16(1):1765.

PMID: 39971907 PMC: 11839950. DOI: 10.1038/s41467-025-56493-7.


Mitochondria as multifaceted regulators of ferroptosis.

Guo J, Zhou Y, Liu D, Wang M, Wu Y, Tang D Life Metab. 2025; 1(2):134-148.

PMID: 39872359 PMC: 11749789. DOI: 10.1093/lifemeta/loac035.


Unraveling Ferroptosis: A New Frontier in Combating Renal Fibrosis and CKD Progression.

Jin R, Dai Y, Wang Z, Hu Q, Zhang C, Gao H Biology (Basel). 2025; 14(1).

PMID: 39857243 PMC: 11763183. DOI: 10.3390/biology14010012.


References
1.
Kuang F, Liu J, Tang D, Kang R . Oxidative Damage and Antioxidant Defense in Ferroptosis. Front Cell Dev Biol. 2020; 8:586578. PMC: 7527737. DOI: 10.3389/fcell.2020.586578. View

2.
Seifert L, Werba G, Tiwari S, Ly N, Alothman S, Alqunaibit D . The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression. Nature. 2016; 532(7598):245-9. PMC: 4833566. DOI: 10.1038/nature17403. View

3.
Barber G . STING: infection, inflammation and cancer. Nat Rev Immunol. 2015; 15(12):760-70. PMC: 5004891. DOI: 10.1038/nri3921. View

4.
Kim J, Kim J, Bae J . ROS homeostasis and metabolism: a critical liaison for cancer therapy. Exp Mol Med. 2016; 48(11):e269. PMC: 5133371. DOI: 10.1038/emm.2016.119. View

5.
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X . Ferroptosis: process and function. Cell Death Differ. 2016; 23(3):369-79. PMC: 5072448. DOI: 10.1038/cdd.2015.158. View